January 15, 2018 (Vol. 38, No. 2)

SYGNIS

The Innova Biosciences Universal Lateral Flow Assay (LFA) kit, provides for the easy, quick development of customized sandwich lateral flow assays. This enables researchers to rapidly progress the R&D of their point-of-care (POC) diagnostic tools thereby providing physicians with faster access to POC testing for rapid early detection of disease. The kit utilizes the company’s antibody-labeling technologies Lightning-Link® and InnovaCoat® Gold and enables customers to create LFA reagents with only a few minutes of hands-on time, without the need to spray down capture antibodies on the test strip, a labor-intensive process that consumes large amounts of expensive antibody reagent. 

Previous articleTumor-Related Immune Checkpoints And The Development Of Targeted Cancer Immunotherapies
Next articleTop 10 Best-Selling Cancer Drugs, Q1–Q3 2017